The topical drugs packaging market will expand further with rising incidence rates of skin diseases, expanding applications of new drug delivery systems, and enhanced convenience packaging requirements. Customized packaging of topical drugs would preserve product integrity, deliver the appropriate dose, and improve patient compliance.
With the introduction of new drug delivery systems as microneedle patches, foams, and transdermal gels by pharmaceutical companies, the requirement for newer packaging is growing. Topical drugs packaging worldwide will be approximately USD 26,876 million in 2025. It will be approximately USD 65,194 million in 2035 at a CAGR of 9.3%.
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 26,876 million |
| Projected Market Size in 2035 | USD 65,194 million |
| CAGR (2025 to 2035) | 9.3% |
Market development is fuelled by the introduction of fresh packaging materials including child-resistant caps, airless pumps, and bioplastics. Topical drugs packaging is fuelled by unprecedented demand from the pain relief, dermatology, and wound care markets to steadily grow through to 2035.
Explore FMI!
Book a free demo
North America represents a growing marketplace for packaging pharma in topicals, motivated by strong pharma R&D, aging population, and high-expectation consumers who seek to self-medicate. The United States dominates the market due to massive green package technology and FDA regulation cost, and as such, packaging safety and innovation is a walkover.
The largest markets are in Europe because of the stringent packaging regulations and R&D activities in drug delivery systems. The largest markets are Germany, the United Kingdom, and France because they are investing in green and smart packaging technologies. The pharmaceuticals of these markets primarily focus on plastic waste reduction and using biodegradable packaging materials while packaging topical drugs.
Asia-Pacific is growing the fastest among markets because of urbanization, rising healthcare consciousness, and more hotspots in China, India, and Japan for pharma manufacturing. Incentivization by government to produce local medication and rising dermatology therapy demand drive specialty topicals drug packing solution markets.
Regulatory Compliance, Material Sustainability, and Counterfeit Packaging
Over-the-counter drug packaging is faced with challenges like regulatory demands to deliver safety, sterility, and tamper evidence. Stability and compatibility of the drugs is assured by requirements for material durability. Counterfeiting packaging is rampant, especially in the emerging economies, and the need arises for adopting anti-counterfeiting technology like QR coding and RFID tagging.
Smart Packaging, Eco-Friendly Materials, and Personalized Drug Delivery
In spite of such a hindrance, the market has huge prospects on the back of technological progress in sensor-based smart packaging and digital monitoring for monitoring patient compliance. Apart from that, pharma businesses also look for more sustainable packaging materials such as recyclable biopolymers and paper tubes with the aim to achieve sustainability targets. Dynamic packaging solutions, being tailored to suit the specific needs of the patients, also hold significance on the back of the upcoming trend of personalized medicine.
The need for topical medicine packaging sensitivity increased between the period of 2020 to 2024 with the increasing usage of over-the-counter dermatology medicine and transdermal drug delivery. The efficiency of production was impacted by the disruption of supply chain and uncertainty in raw material prices.
Sustainability changed at a quicker pace but transporting the biodegradable packing material to the wider market was hindered due to economic challenges. Packaging innovations during 2025 to 2035 will be more integrated with smart tracking technology, high-performance barrier coatings, and completely recyclable material.
There will be more stringent plastic reduction regulations by regulatory authorities, and elastic multi-dose dispensers will be utilized by pharma companies to facilitate the use of medicines by patients. Green, tamper-evident, and technology-based packing will be the new industry standard of packing of topical drugs, and innovation and development trend will continue to expand.
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Compliance with FDA and EU packaging material safety guidelines. |
| Consumer Trends | Demand for compact and travel-friendly topical drug packaging. |
| Industry Adoption | Use of plastic tubes and jars for topical drug formulations. |
| Supply Chain and Sourcing | Reliance on petroleum-based plastic suppliers. |
| Market Competition | Dominated by players like Berry Global, Amcor, and Gerresheimer. |
| Market Growth Drivers | Growth driven by expanding dermatology and pain relief drug markets. |
| Sustainability and Environmental Impact | Introduction of recyclable plastics and minimalistic designs. |
| Integration of Smart Technologies | Use of tamper-evident seals and child-resistant caps. |
| Advancements in Equipment Design | Standardized tube-filling and labeling machinery. |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Adoption of green packaging requirements, child-resistance closures, and more demanding recycling requirements. |
| Consumer Trends | Growing demand for airless pump dispensers and green biodegradable tubes. |
| Industry Adoption | Migration to aluminium and glass pack containers to reduce plastic waste. |
| Supply Chain and Sourcing | More use of plant-based bioplastics and recycled materials in packaging. |
| Market Competition | Incursion of green sustainable packaging niched startups and pharma green-packaging developers. |
| Market Growth Drivers | Driven by need for high-end anti-aging and prescription-strength topical formulations in eco-friendly formats. |
| Sustainability and Environmental Impact | Movement to compost packaging, reusable containers, and carbon-free production. |
| Integration of Smart Technologies | Expansion in NFC packaging for dosage tracking and patient compliance monitoring. |
| Advancements in Equipment Design | Launch of completely automated eco-friendly packaging lines with AI-powered quality inspection. |
The USA topically filled drug market is growing with rising demand for additional dermatological treatments and painkillers. The firms introduced airless pump bottles and tamper evident tubes after a rise in demand for new packaging options.
More drivers for sustainability from top pharmaceutical companies are propelling the transition to recyclable and biodegradable packaging. The trend will also persist with the regulator bodies introducing more stringent rules for plastic reduction.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 9.8% |
Sustainability issues have stirred controversy on the latest in drug packaging technology in the UK Consumers are calling for more sustainable packaging, and drug companies are answering with recycled tubes and paper blister packs. Refill packaging, which reduces waste and is not unique to the beauty sector, is sweeping out new goods onto the cosmetic dermatology aisle, and environmental sustainability gave a competitive edge.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 9.5% |
Strict EU sustainability regulations are revolutionizing the packaging of local medicines. Germany, France, and the Netherlands are witnessing the fast take-up of bioplastic and aluminium-based packaging technologies.
The trend of circular economy is forcing the pharma sector to create reusable and refillable packaging for local medicines. Regulation-driven demand for sustainable material will continue to drive market growth.
| Region | CAGR (2025 to 2035) |
|---|---|
| EU | 9.3% |
The Japanese market is changing with premium and minimalistic packaging types at the forefront. The pharma and skincare markets are adopting smart packaging technology, including the use of QR codes for patient instruction and compliance tracking.
Luxury skincare and Rx creams are driving demand for precision dispensers and UV-stable packaging, driving innovation. Sustainability is also on the increase, with increased usage of bamboo and paper-based materials.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 9.7% |
South Korea is witnessing a rush of demand for eco-friendly and innovative topical pharmaceutical packaging, mostly cosmeceuticals. Cosmeceutical brands from Korea are in the lead using refillable glass packs and bio-plastics sourced from plants for packing their cosmeceutical topical formulations.
Packaging methods like the embracement of airless dispensers and moisture-tracking packs are trending fast. Surging consumerism towards greener alternatives is speeding up packaging innovations at a highly rapid rate.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 9.4% |
| By Product Types | Market Share (2025) |
|---|---|
| Plastic Bottles | 45% |
Plastic bottles are also anticipated to dominate the market for packaging topical medications with a 45% market share in 2025. Plastic bottles are needed because they are durable, affordable, and can seal airtight to ensure the efficacy of the drug is maintained.
Pharmaceutical industries use plastic bottles to enclose liquid and semi-liquid drugs, mainly for use in the eye and nose, because they are lightweight and cannot be broken. Additionally, the technological breakthrough of the high-density polyethylene (HDPE) and polypropylene (PP) material has also contributed to their water- and UV-proof characteristic, thus the shelf life.
Glass packaging, while they hold a lower market share, are still used widely in prestige products where product stability is of utmost importance. They are used on high-value dermatological products which need to be shielded from oxidation. But their susceptibility to break and higher cost than plastic have kept their use in the mass market at a higher level.
| By Nature | Market Share (2025) |
|---|---|
| Liquid | 52% |
Liquid solutions will make up the largest segment of the packaging market for topically administered medications in 2025 and hold a total 52% market share. The category has increased as additional ophthalmic eye drops and nasal sprays require separate packaging for preservation of sterility and specific dosing.
Dropper plastic bottles that allow for multi- and single-dose have increased popularity because it is convenient for the patient to use without jeopardizing sterility. Semi-solid and cream products are a major market segment for dermal use.
But they are a secondary market share for liquid medicines of varying degrees of usage and packaging requirements. Companies are laying emphasis on designing greater compatibility of the packaging material with active pharmaceutical ingredients (APIs) in order to allow longer-term stability for liquid and semi-solid drugs.
Growing demand for green and innovative packaging products in the pharmaceutical sector has led to market expansion for topical drugs packaging. Growing consumer demand for green material, child-resistance, unit-dose packaging, and regulatory compliance have forced manufacturers to offer advanced barrier films, biodegradable plastic materials, and airless dispensing units. Market strategies continue to be dominated by regulatory requirements in pharmaceutical packaging, forcing companies to invest in compliance and tamper-evident designs.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Amcor Plc | 22-26% |
| Gerresheimer AG | 18-22% |
| Berry Global, Inc. | 14-18% |
| AptarGroup, Inc. | 10-14% |
| West Pharmaceutical Services, Inc. | 6-9% |
| Other Companies (combined) | 13-17% |
| Company Name | Key Offerings/Activities |
|---|---|
| Amcor Plc | In 2024, launched a fully recyclable pharmaceutical blister pack to meet sustainability targets. In 2025, released high-barrier pouch packaging with antimicrobial coatings for longer shelf life. |
| Gerresheimer AG | In 2024, increased manufacturing of biocompatible plastic tubes for dermatology use. In 2025, created smart packaging solutions with NFC-enabled authentication for anti-counterfeiting. |
| Berry Global, Inc. | Launched PCR-based (post-consumer recycled) ointment plastic tubes in 2024 . In 2025, teamed up with market-leading pharma brands to offer lightweight, green airless pumps. |
| AptarGroup, Inc. | In 2024, launched metered-dose dispensing solutions for topical creams. In 2025, added its line of child-resistant closures to address rigorous safety standards. |
| West Pharmaceutical Services, Inc. | In 2024, introduced unit-dose sterile packaging systems for its wound care products. In 2025, upgraded its tamper-evident packaging solutions with tracking technology integrated. |
Key Company Insights
Amcor Plc (22-26%)
Amcor is the market leader with a strong portfolio of barrier films and sustainable packaging options. Its pioneering, fully recyclable blister packs and antimicrobial-coated pouches position it as a strong supplier for pharma seeking environmentally friendly options.
Gerresheimer AG (18-22%)
Gerresheimer revolves around premium glass and plastic packaging. Its production of biocompatible tubes out of plastic and its NFC authentication technology ensure added security and safety for patients, most needed in topical drug administration and dermatological applications.
Berry Global, Inc. (14-18%)
Berry Global has been leveraging its sustainable plastics leadership to manufacture PCR-based tubes as well as reduced-weight airless pumps. Its collaboration with dominant drug makers has strengthened its base of customers for green packaging.
AptarGroup, Inc. (10-14%)
AptarGroup provides precise drug delivery by specializing in metered-dose pumps and child-resistant closures. Its compliance and safety focus enables drug manufacturers to be compliant with stringent packaging requirements.
West Pharmaceutical Services, Inc. (6-9%)
West Pharmaceutical Services functions best with tamper-evident and sterile packaging. Its unit-dose monitoring combined with sophisticated unit-dose packaging offers greater security and quality control to drug companies.
Other Key Players (13-17% Combined)
The overall market size for the topical drugs packaging market was USD 26,876 million in 2025.
The topical drugs packaging market is expected to reach USD 65,194 million by 2035.
The increasing prevalence of dermatological conditions, advancements in drug formulations, and the growing demand for convenient and user-friendly packaging solutions are fueling the demand for topical drugs packaging during the forecast period.
The top 5 countries driving the development of the topical drugs packaging market are the United States, Germany, the United Kingdom, China, and Japan.
On the basis of packaging type, the flexible packaging segment is projected to hold a significant share over the forecast period.
BOPP Film Market Analysis by Thickness, Packaging Format, and End-use Industry Through 2025 to 2035
Korea Tape Dispenser Market Analysis by Material, Product Type, Technology, End Use, and Region through 2025 to 2035
Medical Transport Box Market Trend Analysis Based on Material, Capacity, End-User and Regions 2025 to 2035
Japan Heavy-duty Corrugated Packaging Market Analysis based on Product Type, Board type, Capacity, End use and City through 2025 to 2035
Corrugated Board Market Analysis by Material and Application Through 2035
Waterproof Packaging Market Trends - Demand & Industry Forecast 2025 to 2035
Topical Drugs Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
